News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
2013
Sources here
23
Companies here
30
Search results Stored financial headlines

Active search

2013 matching headlines

Ticker or company: LABMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares

Representative Mike Kelly sold shares of Abbott Laboratories (NYSE:ABT) valued between $1,001 and $15,000 on July 17th, as well as shares of PepsiCo and Walt Disney on the same day. This sale occurred despite Abbott Laboratories reporting a quarterly earnings beat and reaffirming its …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bio Rad Laboratories (BIO) Issues Flat Revenue Guidance, Is It Too Far Above Fair Value?

Bio-Rad Laboratories (BIO) has seen a sharp increase in its stock price over the last 90 days, despite recent flat revenue guidance and a significant long-term decline in shareholder return. The company is currently trading above its fair value estimate of $293, driven by …

BIO main company BIO-B main company
Sharemaestro market context Trend signal active 52 weeks +17.3% BIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ZLAB - Expanding China Healthcare And Global Pipelines Will Broaden Patient Options

Zai Lab's fair value has been adjusted slightly lower to $33.30, yet the company is broadening patient options through expanding its China healthcare presence and global pipelines. Key developments include regulatory approvals for TIVDAK in China, Orphan Drug Designation for zocilurtatug pelitecan in Europe, …

ZLAB main company
Sharemaestro market context Trend signal active 52 weeks -26.1% ZLAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Zai Lab’s (ZLAB) Rising Losses for Pipeline Expansion Strengthening or Straining Its Investment Case?

Zai Lab (ZLAB) reported widening net losses and softer revenue in Q2 2026, primarily due to increased investment in pipeline expansion and commercial footprint. While recent drug approvals like TIVDAK offer future revenue potential, the key challenge for Zai Lab is whether these new …

ZLAB main company
Sharemaestro market context Trend signal active 52 weeks -26.1% ZLAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected …

IDXX main company I1DX34 main company IDXX main company IX1 main company IDXX main company
Sharemaestro market context Price above Trend Line 52 weeks -13.7% · Next-week setup negative 32.7% IDXX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RKLB Stock Slips Overnight: Rocket Lab Tops 400 Archimedes Hot Fires, Neutron Engine Set Enters Production

Rocket Lab's Archimedes engine has completed over 400 hot-fire tests, with the full engine set for the Neutron rocket's maiden launch now in production. Despite this progress, RKLB stock slipped 0.5% overnight and is down 2% for the week. The company aims for a …

RKLB main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% · Next-week setup positive 55.7% RKLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Is Rocket Lab (NASDAQ: RKLB) Stock? Electron, Neutron, Space Systems, Iridium and Growth Opportunities

Rocket Lab Corporation (NASDAQ: RKLB) is an end-to-end space company offering launch services, spacecraft manufacturing, and satellite components, among other space systems. Key growth pillars include expanding Electron and HASTE launch activities, developing the reusable Neutron rocket, growing Space Systems, increasing government exposure, and …

RKLB main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% · Next-week setup positive 55.7% RKLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Silicon Labs (SLAB) Stock Carries A Premium As Losses Persist

Silicon Laboratories (SLAB) stock remains highly valued despite continuing to report net losses and negative basic earnings per share. While Q2 2026 results showed narrowed losses and increased revenue driven by IoT segments, concerns persist regarding the company's profitability and execution risk, especially with …

SLAB main company
Sharemaestro market context Trend signal active 52 weeks +50.5% SLAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks

Congressman Mike Kelly recently executed several trades through the Victoria Kelly Trust ICA, including selling stocks from Abbott Laboratories and The Walt Disney Company, each valued between $1,001 and $15,000. He also sold Pepsico, Inc. stocks worth $15,001 to $50,000. Additionally, Kelly purchased government …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rocket Lab USA Inc. (RKLB) rebounds as weekly confirmation stays weak

A 27.5% one-week advance lifted the shares, but the weekly price path over 52 weeks still shows a negative 12-week return.

RKLB main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% · Next-week setup positive 55.7% RKLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VivoSim: Fiscal Q1 Earnings Snapshot

VivoSim Labs, Inc. (VIVS) reported a fiscal first-quarter loss of $1.3 million, or 25 cents per share. The San Diego-based development-stage company, which focuses on functional human tissue for research, posted revenue of $18,000 for the period.

VIVS main company
Sharemaestro market context Price below Trend Line 52 weeks -84.7% · Next-week setup negative 38.4% VIVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABT main company ABT main company ABTT34 main company ABT main company ABT main company ABL main company
Sharemaestro market context Price above Trend Line 52 weeks -1.0% · Next-week setup positive 57.3% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dolby Laboratories (DLB) VP Nicholson sells 1,348 Class A shares at $62.04

Ryan Nicholson, VP, CAO and Corporate Controller of Dolby Laboratories (DLB), sold 1,348 shares of Class A common stock at $62.04 per share on August 10, 2026. Following this transaction, Nicholson directly holds 35,636 shares, which includes 19,303 shares of restricted stock units that …

DLB main company
Sharemaestro market context New activity signal 52 weeks -16.1% DLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Abbott Laboratories stock outperforms competitors on strong trading day

Shares of Abbott Laboratories (ABT) rose 1.08% to $110.91, marking its third consecutive day of gains. This performance occurred on a mixed trading day where the S&P 500 Index increased by 0.26% and the Dow Jones Industrial Average fell by 0.04%. The stock's positive …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Labcorp president & CEO Adam Schechter sells $1.5m in company stock

Adam H. Schechter, President & CEO of Labcorp Holdings Inc., sold 4,669 shares of company stock for approximately $1.5 million. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan. This transaction occurred as LH stock traded near its 52-week high, following …

LH main company
Sharemaestro market context Trend signal active 52 weeks +15.6% LH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rocket Lab CEO Won’t Take on Musk and Bezos in Broadband: ‘The Two Most Wealthiest People in the World Are Going After That’

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. On Monday, Rocket Lab Corp. CEO Peter Beck said the company's planned $8 billion acquisition of Iridium Communications Inc. is opening a new space-services opportunity — one …

RKLB main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% · Next-week setup positive 55.7% RKLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Selling: Labcorp (NYSE:LH) CEO Sells 4,669 Shares of Stock

Labcorp CEO Adam Schechter sold 4,669 shares of company stock for approximately $1.50 million under a pre-arranged trading plan, reducing his total ownership by 4.35%. This sale occurred while Labcorp shares traded near their 52-week high, following strong quarterly earnings that surpassed analyst expectations. …

LH main company
Sharemaestro market context Trend signal active 52 weeks +15.6% LH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Astera Labs Inc Stock (ALAB) Moved Up by 6.11% on Aug 12: Key Drivers Unveiled

Astera Labs Inc (ALAB) saw its stock price increase by 6.11% on August 12, driven by strong quarterly financial results that surpassed expectations and robust demand for its semiconductor connectivity solutions in AI infrastructure. Analyst upgrades and positive market sentiment surrounding AI deployment also …

ALAB main company ALAB main company
Sharemaestro market context Trend signal active 52 weeks +56.7% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GitLab Chief Accounting Officer Simon Mundy Sells 8,725 Shares

Key Points Simon Mundy sold 8,725 shares for a total value of $331,550 on August 7, 2026. The transaction reduced the executive's direct equity position by 8% of total holdings. The sale was executed under a Rule 10b5-1 trading plan established on June 23, …

GTLB main company
Sharemaestro market context Trend signal active 52 weeks -5.7% · Next-week setup positive 55.1% GTLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Astera Labs (NASDAQ:ALAB) Shares Gap Up - Should You Buy?

Astera Labs (NASDAQ:ALAB) shares gapped up by 6.6% to $334.49, driven by optimism for AI connectivity products and strong financial results including 104.5% year-over-year revenue growth. Northland Securities significantly raised its earnings forecasts for the company, while AMD's Helios AI systems are anticipated to …

ALAB main company
Sharemaestro market context Trend signal active 52 weeks +79.6% · Next-week setup positive 59.8% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The Abbott Big Ten $1 Million Blood Drive is Back

The Abbott Big Ten $1 Million Blood Drive returns for its third year, with Nebraska aiming to reclaim the title from Wisconsin. The competition, which runs from August 26th to December 4th, encourages donations to help address a national blood crisis, with a $1 …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALAB Benefits From PCIe Demand: Can It Stay Ahead of Its Competitors?

Astera Labs (ALAB) is experiencing significant growth due to high demand for PCIe solutions, especially in AI infrastructure, with record revenues in Q2 2026 and strong projections for Q3. The company's diverse product portfolio and focus on next-generation technologies like PCIe 6, UALink, and …

ALAB main company ALAB main company
Sharemaestro market context Trend signal active 52 weeks +56.7% ALAB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Labcorp Holdings (LH) is in focus after a series of oncology diagnostics approvals and launches, including the PGDx elio tissue complete CDx for advanced …

LH main company
Sharemaestro market context Trend signal active 52 weeks +15.6% LH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rocket Lab Shares Surge: What's Driving the Rally

Rocket Lab's (NASDAQ: RKLB) stock has been on a tear again in early August, riding a wave of enthusiasm that started with a blowout first quarter, and it seems to now be fueled by another strong report in the second quarter. For a company …

RKLB main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% · Next-week setup positive 55.7% RKLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ecolab Inc. stock underperforms Wednesday when compared to competitors

Ecolab Inc. (ECL) stock fell by 2.18% on Wednesday, closing at $278.43. This performance was amidst a mixed trading session where the S&P 500 rose and the Dow Jones Industrial Average slightly declined. The stock is currently 9.97% below its 52-week high.

ECL main company
Sharemaestro market context Price above Trend Line 52 weeks -1.6% · Next-week setup positive 59.8% ECL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Proto Labs (PRLB) Upgraded to Strong Buy: Here's Why

Proto Labs (PRLB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The …

PRLB main company PRLB main company
Sharemaestro market context Trend signal active 52 weeks +81.2% PRLB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context